Resistencia a la insulina como factor desencadenante de dislipidemia

Roberto Alejandro Pérez Freire; Ana Gabriela Pacha Jara

doi:10.56294/saludcyt2022163

Review

Published: 2022-12-25

DOI: https://doi.org/10.56294/saludcyt2022163

Insulin resistance as a triggering factor of dyslipidemia

Abstract

Insulin resistance (IR) is defined as a pathological state that is characterized by a decrease in the sensitivity of insulin in the tissues, on the other hand, dyslipidemia is a lipid level alteration that could develop from insulin resistance. This bibliographic review describes the main scientific contributions that demonstrate whether insulin resistance is one of the essential pathological conditions for developing some of the diseases that constitute serious public health problems, such as dyslipidemia, type 2 diabetes mellitus (DM2) and metabolic syndrome (MS).

Keywords:

Insulin Resistance,

Dyslipidemias,

Type 2 Diabetes Mellitus,

How to Cite

Pérez Freire RA, Pacha Jara AG. Insulin resistance as a triggering factor of dyslipidemia. Salud, Ciencia y Tecnología [Internet]. 2022 Dec. 25 [cited 2024 Apr. 18];2:163. Available from: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/163

Copyright Notice

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

Article metrics

Google scholar: See link

Metrics

Metrics Loading ...

Vol. 2 (2022)

See full issue

Revistas/Journals

Issue

About

Author Guidelines